AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7552929
Drug: Topical levocabastine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical levocabastine
Trial: 8101534
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered terfenadine
Trial: 27448679
Drug: Intravenous-to-oral solithromycin
RxNorm normalized name: roxithromycin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous-to-oral solithromycin
Trial: 27448679
Drug: Intravenous-to-oral moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous-to-oral moxifloxacin
Trial: 14512102
Drug: Higher methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher methadone doses (more than 80 mg)
Trial: 14512102
Drug: Psychopharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychopharmacological treatment associated with methadone
Trial: 14512102
Drug: Weekly or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly or twice weekly methadone administration
Trial: 10855941
Drug: Prolonged courses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged courses of steroids
Trial: 10855941
Drug: Cyclosporine A
RxNorm normalized name: CycloSPORINE A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine A and cytotoxic agents
Trial: 10855941
Drug: Pulse methylprednisolone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse methylprednisolone, azathioprine, tacrolimus, mycophenolate mofetil, combination therapy
Trial: 25192967
Drug: Mean oral
RxNorm normalized name: OCTINOXATE 5 mg in 100 mL / AVOBENZONE 3 mg in 100 mL TOPICAL LOTION [Meaningful Beauty Cindy Crawford Maintenance 1 Daily Moisture SPF 8]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mean oral morphine intake
Trial: 20200939
Drug: Ibuprofen (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (400 mg) before exercise
Trial: 20200939
Drug: Placebo before,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo before, ibuprofen after
Trial: 17881719
Drug: CEP-1347 10
RxNorm normalized name: CEP-1347
DrugBank: CEP-1347 (DB05403)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEP-1347 10 mg BID
Trial: 17881719
Drug: CEP-1347 25
RxNorm normalized name: CEP-1347
DrugBank: CEP-1347 (DB05403)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEP-1347 25 mg BID
Trial: 17881719
Drug: CEP-1347 50
RxNorm normalized name: CEP-1347
DrugBank: CEP-1347 (DB05403)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEP-1347 50 mg BID
Trial: 15674304
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (males: 300 ml/day, 38.3 g alcohol/day; females: 200 ml/day, 25.5 g alcohol/day)
Trial: 23554113
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg once daily for 5 days
Trial: 18339162
Drug: Propofol 1
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1 mg/kg
Trial: 7788197
Drug: Thiopentone 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 1.5 mg/kg
Trial: 12123540
Drug: Raloxifene 60
RxNorm normalized name: raloxifene 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 60 mg daily
Trial: 15146102
Drug: Combined conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined conjugated equine estrogen 0.625 mg and medroxyprogesterone acetate 5 mg daily (CCEP)
Trial: 11593317
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with doxorubicin/G-CSF followed by high-dose chemotherapy (HDC) with CTCb and melphalan, and dose-escalated paclitaxel at 475 mg/m2
Trial: 9817491
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional treatment (CABG alone)
Trial: 18463448
Drug: 2‐compound scalp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2‐compound scalp formulation (calcipotriol plus betamethasone dipropionate)
Trial: 17337492
Drug: Telmisartan 40/80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40/80 mg
Trial: 12900588
Drug: Losartan 50/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50/100 mg
Trial: 31505986
Drug: Locally acting
RxNorm normalized name: Corticosteroids acting locally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locally acting generic drug (T)
Trial: 31505986
Drug: Innovator drug
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Innovator drug (R)
Trial: 29570772
Drug: 81 mg
RxNorm normalized name: aspirin 81 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 81 mg daily aspirin for 3 years
Trial: 29570772
Drug: 325 mg
RxNorm normalized name: lysine 325 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 325 mg daily aspirin for 3 years
Trial: 7341219
Drug: Atropine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.5 mg s.c.)
Trial: 7341219
Drug: Neostigmine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (0.5 mg s.c.)
Trial: 27553192
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin lispro
Trial: 22385260
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg systemic doxycycline (DOXY) for 7 days after surgery
Trial: 19670918
Drug: pioglitazone (15-45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone (15-45 mg once daily)
Trial: 17454066
Drug: Galantamine hydrobromide
RxNorm normalized name: Galantamine Hydrobromide
DrugBank: Galantamine (DB00674)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Galantamine hydrobromide dispersible tablet (10 mg)
Trial: 17454066
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (conventional tablet)
Trial: 15281473
Drug: Budesonide aqueous
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide aqueous nasal spray (64 microg/d)
Trial: 12215757
Drug: Ximelagatran/Melagatran (highest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ximelagatran/Melagatran (highest dose)
Trial: 12215757
Drug: Ximelagatran/Melagatran (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ximelagatran/Melagatran (24 mg, twice daily)
Trial: 12215757
Drug: Enoxaparin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (40 mg, once daily)
Trial: 12215757
Drug: Dalteparin (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (5000 IE, once daily)
Trial: 12215757
Drug: Melagatran (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melagatran (3 mg, twice daily)
Trial: 9579164
Drug: Regular inhaled
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular inhaled corticosteroids
Trial: 8563223
Drug: IgA and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgA and IgG gliadin antibodies (AGA) and IgA endomysium antibodies (EMA) in coeliac disease (CD)
Trial: 657100
Drug: G.A.T.L.A. protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G.A.T.L.A. protocol (vincristine-prednisone plus surgery and/or radiotherapy, craniocervical radiotherapy, intrathecal methotrexate, anti-leukemia and anti-lymphoma treatments)
Trial: 657100
Drug: No uniform
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No uniform treatment (1966-1972 group)
Trial: 31489024
Drug: Micro‐traumatic evacuation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro‐traumatic evacuation of cerebral hemorrhage with conventional symptomatic treatment (Control)
Trial: 17874489
Drug: Coitus at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coitus at least once weekly
Trial: 15181067
Drug: Troglitazone, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone, 400 mg/d (early intervention)
Trial: 3706675
Drug: New inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New inhalation technique (shrug of the shoulder method)
Trial: 3706675
Drug: Conventional inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional inhalation technique
Trial: 30498336
Drug: Cucumis sativus
RxNorm normalized name: CUCUMIS SATIVUS LEAF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cucumis sativus extract (CSE) 10 mg twice daily
Trial: 30498336
Drug: Glucosamine-chondroitin (GC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucosamine-chondroitin (GC) 1,350 mg twice daily
Trial: 20965814
Drug: Standard anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard anticoagulant intensity with warfarin (INR maintained between 2.0 and 3.0)
Trial: 7865650
Drug: Phenolphthalein glucuronide
RxNorm normalized name: menthol glucuronide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenolphthalein glucuronide equivalent to 30 mg phenolphthalein
Trial: 7865650
Drug: Phenolphthalein (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenolphthalein (doses of 15, 30, 45, 60, 75, and 90 mg)
Trial: 7865650
Drug: Phenolphthalein glucuronide
RxNorm normalized name: menthol glucuronide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenolphthalein glucuronide (doses of 24, 48, 72, 96, 120, and 144 mg)
Trial: 2802557
Drug: Ofloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (200 mg) twice daily for 3 days
Trial: 2802557
Drug: Ofloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (200 mg) twice daily for 7 days
Trial: 2802557
Drug: Ofloxacin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (300 mg) twice daily for 7 days
Trial: 2802557
Drug: Trimethoprim-sulfamethoxazole (160/800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole (160/800 mg) twice daily for 7 days
Trial: 1096686
Drug: Pyridoxine therapy
RxNorm normalized name: PYRIDOXINE
DrugBank: Pyridoxine phosphate (DB02209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pyridoxine therapy (200 mg daily)
Trial: 31629372
Drug: Oral Zhiqiao
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Zhiqiao Gancao (ZQGC) decoction
Trial: 31629372
Drug: Oral anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anti-inflammatory drug celecoxib
Trial: 23324098
Drug: AZD1940 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1940 (400 μg)
Trial: 23324098
Drug: AZD1940 (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1940 (800 μg)
Trial: 20971614
Drug: GH+Ox 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH+Ox 0.03 mg/kg/d
Trial: 20971614
Drug: GH+Ox 0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH+Ox 0.06 mg/kg/d
Trial: 19935025
Drug: Periodontal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal treatment starting around 20 weeks of gestation (n=542)
Trial: 19935025
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving no treatment until 6 weeks after pregnancy (n=540)
Trial: 16908486
Drug: TGN1412 (anti-CD28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TGN1412 (anti-CD28 monoclonal antibody)
Trial: 11710402
Drug: Creatine (Cr)
DrugBank: Creatine (DB00148)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Creatine (Cr) 20 g for 5 days
Trial: 26283229
Drug: SMS text
RxNorm normalized name: Samarium Sm-153
DrugBank: Samarium Sm-153 (DB12905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SMS text reminders for adherence to artemether-lumefantrine and post-treatment review
Trial: 23507773
Drug: 20 IU
RxNorm normalized name: Calcium/Phosphorus/Vitamin D 105 MG-81 MG-120 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 IU of intranasal insulin
Trial: 23507773
Drug: 40 IU
RxNorm normalized name: Oxytocin 40 IU/1 ML Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 IU of intranasal insulin
Trial: 23507773
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (both doses)
Trial: 16899712
Drug: Water (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water (240 ml)
Trial: 9040055
Drug: MCAF/MCP-1 in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCAF/MCP-1 in myocardial infarction at 3 hours (133 +/- 19 pg/ml)
Trial: 9040055
Drug: MCAF/MCP-1 in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCAF/MCP-1 in myocardial infarction at 9 hours (143 +/- 20 pg/ml)
Trial: 9040055
Drug: MCAF/MCP-1 in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCAF/MCP-1 in myocardial infarction at 24 hours (168 +/- 13 pg/ml)
Trial: 3309198
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy as prophylaxis
Trial: 23672224
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine
Trial: 27853872
Drug: Psychosomatic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosomatic treatment for the elderly (5-week therapy)
Trial: 24477298
Drug: EVEN protein
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: EVEN protein distribution (31.5 ± 1.3 g at breakfast, 29.9 ± 1.6 g at lunch, 32.7 ± 1.6 g at dinner)
Trial: 24477298
Drug: SKEW protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SKEW protein distribution (10.7 ± 0.8 g at breakfast, 16.0 ± 0.5 g at lunch, 63.4 ± 3.7 g at dinner)
Trial: 22704410
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba leaf tablets, 19.2 mg each dose, taken 3 times a day for 6 months
Trial: 20728068
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard analgesic administration)
Trial: 18462573
Drug: SSRIs +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRIs + Cognitive Behaviour Therapy (CBT)
Trial: 20201179
Drug: Rocuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.1 mg/kg
Trial: 23877864
Drug: Succinylcholine 1
RxNorm normalized name: Succinylcholine 124 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine 1 mg/kg
Trial: 8832448
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg/kg, Atracurium 0.5 mg/kg, Succinylcholine 1 mg/kg
Trial: 20515217
Drug: Interpersonal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal therapy
Trial: 6381019
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of a mean of 298 mg levodopa and benserazide plus 17 mg bromocriptine
Trial: 6381019
Drug: Mean dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mean dosage of 444 mg levodopa and benserazide
Trial: 24335227
Drug: Intravenous tissue-type
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tissue-type plasminogen activator (tPA) plus endovascular therapy
Trial: 24335227
Drug: Intravenous tPA
RxNorm normalized name: tPA
DrugBank: Phorbol 12-myristate 13-acetate diester (DB17045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tPA therapy alone
Trial: 15864937
Drug: Tramadol infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol infusion (1 mg/kg loading dose at skin closure and 0.2 mg/kg/h postoperative infusion)
Trial: 15864937
Drug: Morphine PCA
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine PCA alone (control group received saline infusion)
Trial: 9088586
Drug: Frusemide (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (40 mg daily for 4 days)
Trial: 8154887
Drug: Continuous treatment
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous treatment with 5'-DFUR at a daily oral dose of 600 mg/patient
Trial: 8154887
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment with 5'-DFUR for 2 weeks at a daily oral dose of 1,200 mg/patient followed by 2 weeks of no treatment
Trial: 8154887
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment regimens (continuous and intermittent)
Trial: 14499204
Drug: Primidone 250
RxNorm normalized name: primidone 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primidone 250 mg/day (G 250)
Trial: 14499204
Drug: Primidone 750
RxNorm normalized name: Primidone
DrugBank: Primidone (DB00794)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Primidone 750 mg/day (G 750)
Trial: 6756932
Drug: Metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 100 mg b.i.d. (twice daily)
Trial: 4054194
Drug: Metoprolol 200
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 200 mg once daily
Trial: 6756932
Drug: Chlorthalidone 25
RxNorm normalized name: chlorthalidone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 25 mg added after 2 weeks of Metoprolol 100 mg b.i.d.
Trial: 6756932
Drug: Metoprolol 200
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 200 mg b.i.d. (twice daily)
Trial: 29913292
Drug: Single-level transforaminal
RxNorm normalized name: transforming growth factor beta 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-level transforaminal lumbar interbody fusion (TLIF) for Group L (non-kyphotic alignment)
Trial: 22051941
Drug: PHEN/TPM CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHEN/TPM CR 3.75/23 mg
Trial: 22051941
Drug: PHEN/TPM CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHEN/TPM CR 15/92 mg
Trial: 19652065
Drug: Trabectedin 0.58
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabectedin 0.58 mg/m² 3-hour IV infusion every week for 3 weeks of a 4-week cycle (qwk 3-hour)
Trial: 6352278
Drug: Levonantradol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonantradol (0.5 mg)
Trial: 6352278
Drug: Levonantradol (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonantradol (higher doses)
Trial: 28661585
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 300 U/mL (Gla‐300)
Trial: 28661585
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 100 U/mL (Gla‐100)
Trial: 18161398
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg twice a day)
Trial: 20723260
Drug: Fesoterodine 8
RxNorm normalized name: fesoterodine 8 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fesoterodine 8 mg
Trial: 11426582
Drug: Pravastatin (10‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (10‐20 mg/day)
Trial: 31005386
Drug: Phenytoin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (20 mg/kg intravenous or intraosseous infusion over 20 min)
Trial: 31005386
Drug: Levetiracetam (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam (40 mg/kg intravenous or intraosseous infusion over 5 min)
Trial: 3115833
Drug: Subcutaneous leuprolide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous leuprolide (500 micrograms/day)
Trial: 27706483
Drug: Micafungin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micafungin (100 mg, once daily, for 14 days)
Trial: 25569053
Drug: Subcutaneous suture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous suture
Trial: 25569053
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no subcutaneous suture)
Trial: 23678038
Drug: Oral 17β-estradiol
RxNorm normalized name: 17β-estradiol
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 17β-estradiol (E₂) at a mean dose of 2 mg
Trial: 23678038
Drug: Transdermal 17β-estradiol
RxNorm normalized name: 17β-estradiol
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17β-estradiol (E₂) at a mean dose of 0.1 mg
Trial: 20519423
Drug: Fentanyl 1
RxNorm normalized name: fentanyl 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1 mL (50 microg) added to local anesthetics
Trial: 20519423
Drug: Saline placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline placebo 1 mL
Trial: 14669194
Drug: High-frequency vibration
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-frequency vibration training (28Hz) for three 2-minute sessions, twice weekly for 6 months
Trial: 10974208
Drug: CDP‐choline (citicoline;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP‐choline (citicoline; 500 mg)
Trial: 10974208
Drug: CDP‐choline (citicoline;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP‐choline (citicoline; 2000 mg)